XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Oct. 28, 2023
Jul. 29, 2023
Apr. 29, 2023
Jan. 28, 2023
Oct. 29, 2022
Jul. 30, 2022
Oct. 28, 2023
Oct. 29, 2022
Apr. 29, 2023
Statement of Cash Flows [Abstract]                  
Net income (loss) $ 39,855 $ 31,130 $ 74,842 $ 53,847 $ 53,649 $ 24,260 $ 70,985 $ 77,909  
Adjustments to reconcile net income to net cash used in operating activities:                  
Depreciation             23,583 22,412  
Amortization             19,253 18,678  
Non-cash employee compensation             11,650 8,393  
Non-cash losses (gains) and other, net             3,166 5,085  
Change in assets and liabilities:                  
Receivables             (487,186) (508,811)  
Inventory             (67,416) (100,596)  
Accounts payable             (30,911) 41,557  
Accrued liabilities             (24,908) (47,519)  
Other changes from operating activities, net             (3,492) (37,269)  
Net cash used in operating activities             (485,276) (520,161)  
Investing activities:                  
Additions to property and equipment and software             (33,467) (26,779)  
Collection of DPP receivable             489,452 489,639  
Payments related to acquisitions, net of cash acquired             (1,108) 0  
Payments related to investments             0 (15,000)  
Net cash provided by investing activities             454,877 447,860  
Financing activities:                  
Dividends paid             (50,331) (50,732)  
Repurchases of common stock             (90,491) (15,000)  
Payments on long-term debt             (1,500) 0  
Draw on revolving credit             125,000 145,000  
Other financing activities             4,141 (1,766)  
Net cash provided by (used in) financing activities             (13,181) 77,502  
Effect of exchange rate changes on cash             (2,203) (6,935)  
Net change in cash and cash equivalents             (45,783) (1,734)  
Cash and cash equivalents at beginning of period   $ 159,669   $ 140,280   $ 142,014 159,669 142,014 $ 142,014
Cash and cash equivalents at end of period $ 113,886   $ 159,669   $ 140,280   113,886 140,280 $ 159,669
Supplemental disclosure of non-cash investing activity:                  
Noncash investments acquired             $ 465,058 $ 479,797